Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study
Authors:
- 1 July 2018
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 392 (10142) , 134-144
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Possible predictors for relapse from etanercept discontinuation in ankylosing spondylitis patients in remission: a three years’ following-up studyClinical Rheumatology, 2017
- Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over timeRheumatology, 2017
- Brief Report: Calculating the Ankylosing Spondylitis Disease Activity Score If the Conventional C‐Reactive Protein Level Is Below the Limit of Detection or If High‐Sensitivity C‐Reactive Protein Is Used: An Analysis in the DESIR CohortArthritis & Rheumatology, 2014
- Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysisThe European Journal of Health Economics, 2014
- Disease activity after the discontinuation of biological therapy in inflammatory rheumatic diseasesClinical Rheumatology, 2014
- Long‐Term Efficacy of Adalimumab After Drug Withdrawal and Retreatment in Patients With Active Non–Radiographically Evident Axial Spondyloarthritis Who Experience a FlareArthritis & Rheumatism, 2013
- Adalimumab with or without Methotrexate in Juvenile Rheumatoid ArthritisNew England Journal of Medicine, 2008
- Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitisRheumatology, 2004
- Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label studyRheumatology, 2002
- Etanercept in Children with Polyarticular Juvenile Rheumatoid ArthritisNew England Journal of Medicine, 2000